Thanks to @quirogad & @jane_meisel for taking us through the latest in #PARPi tx in HER2- #mBC.

🔑 to ⬆️access to germline 🧬🧪 & to increasingly think in terms of patient-centered outcomes & QoL.
Inspired this holiday season by the potential to improve outcomes for patients!
---
RT @JohnEbbenMDPhD
@TumorBoardTues @jane_meisel @quirogad @MPishvaian @BreastCaupdates @BreastCancerNow @TNBCFoundation @ArielleMedford 2/5 #TumorBoardTues…
https://twitter.com/JohnEbbenMDPhD/status/1606104321032085511

⏰ Countdown to 8p ET has begun!
✅Answer #PreTest polls in the tweet below👇
🕗 Tune in w #TumorBoardTues & @shilpaonc @katy_beckermann & @brian_rini
🔁Retweet & tag colleagues🩺
🏆 Claim your CME

Simple as 🔢
---
RT @TumorBoardTues
1/🛎️#TumorBoardTuesday #OncTwitter #NephTwitter
#RenalCell wk continues🔁

🗓️Thu 12.15 @ 8p ET

⚙️Mnging AEs w TKI/IO combos

#CME ℹ️🔗http://bit.ly/3iLN6aX
Supported by edu grants from Eisai & @Merck
🚨Be rea…
https://twitter.com/TumorBoardTues/status/1603277070884216833